Empowered Patients, Value, and Digital are Driving Us to a New Health Model | Deloitte US has been saved
Limited functionality available
By Brett J. Davis, general manager & principal | ConvergeHealth by Deloitte, Deloitte Consulting LLP
Five years ago—recognizing that the shift to value-based, personalized health care would have a profound and transformational impact on the industry—we launched ConvergeHEALTH. Our goal was to team up with leading health care institutions, technology companies, life sciences innovators, and patient advocacy groups to create new platforms and solutions to support this transformation for the benefit of patients.
Advances in science, the digitization of health, and insights from the resulting real-world data made it possible to develop this new entity. Our five-year journey has given us the opportunity to work with many talented individuals and organizations to accomplish a common goal: Determine how technology can be used to improve the health of patients and to benefit society. As we look forward to the next five years, I wanted to share five observations that we believe will continue to drive us toward a value-based and personalized health care model:
As I look to the future, I am excited and optimistic about what lies ahead. We are truly at the beginning of the digital and data driven transformation of health care.
Brett Davis is Deloitte Consulting’s Global Assets Leader where he has responsibilities across a portfolio of high growth asset enabled consulting offerings that are powered by innovative new technologies. In this role, he leads the development of portfolio strategy, investment prioritization, go-to-market and commercial enablement, as well as the establishment of new client engagement models and transfer of intellectual property across priority markets. He was previously the founder and General Manager of ConvergeHEALTH, a business unit focused on supporting the information based transformation of healthcare and life sciences that he founded and launched in 2014. In this role he was responsible for managing Deloitte’s $200M+ investment in new digital engagement and advanced analytics platforms to support the industry’s shift to value based, personalized healthcare. Today, ConvergeHEALTH platforms are live in 23 countries supporting millions of patients and leading biopharmaceutical and healthcare clients in their digital transformations. In addition to his role at Deloitte, Davis serves on the External Advisory Board of the University of Pennsylvania’s Department of Medical Ethics and Health Policy. Previously he served as a Board member of the Personalized Medicine Coalition for 6 years, and as an external advisor to the Jefferson School of Population Health and Ben & Catherine Ivy Cancer Foundation. He has been a keynote speaker at numerous industry conferences including HIMSS, AMIA, DIA, ASCO, the National Chamber of Commerce Health Summit, Personalized Medicine World Conference, Harvard Partners Personalized Medicine Conference, and the Annual National Quality Colloquium. Brett has published numerous white papers on the transformative impact of health information technology, and been quoted in publications such as the London Times, InformationWeek, Advanced Clinical Trials, Computer World, Health Data Management, and Bio-IT World. Prior to joining Deloitte, Davis held leadership roles in life sciences and healthcare at Oracle and IBM.